Internal Medicine, Hematology & Oncology · Pembroke Pines, FL
NPI
1922030071
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
801 N Flamingo Rd, Suite 11
Pembroke Pines, FL, 33028
Phone (954) 844-6868
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
552 services
Medicare patients, 2024
150
Average age 74
Drug cost, 2024
$3.3M
519 prescriptions
Company payments, 2025
$33K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luis E Raez was code 99214 (office e&m - established), 365 times for 95 patients. In total Luis E Raez billed 552 services in 10 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 365 | 95 | $72.40 | $26K |
| 99214 Office E&M - Established | Office | 70 | 30 | $80.61 | $5,642 |
| 99233 Hospital E&M - Subsequent | Facility | 49 | 28 | $94.06 | $4,609 |
| 99222 Hospital E&M - Initial | Facility | 19 | 17 | $100.07 | $1,901 |
| 99204 Office E&M - New | Facility | 17 | 17 | $101.79 | $1,730 |
By year: 2022 $47K for 611 services; 2023 $43K for 563 services; 2024 $42K for 552 services.
Medicare prescription drug claims, 2024
In 2024, the drug Luis E Raez prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 105 prescriptions and refills. In total Luis E Raez wrote 519 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 105 | 105 | 12 | $1.7M |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 51 | 51 | 14 | $804 |
| Gilotrif Afatinib Dimaleate | 27 | 27 | Under 11 | $299K |
| Ondansetron Odt Ondansetron | 21 | 21 | 17 | $216 |
| Azithromycin Generic | 17 | 17 | 12 | $60.86 |
| Xarelto Rivaroxaban | 16 | 16 | Under 11 | $9,117 |
| Folic Acid Generic | 15 | 25 | Under 11 | $64.56 |
| Tepmetko Tepotinib Hcl | 14 | 14 | Under 11 | $350K |
| Xalkori Crizotinib | 13 | 13 | Under 11 | $277K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 13 | 15 | Under 11 | $151 |
| Eliquis Apixaban | 13 | 21 | Under 11 | $12K |
| Prednisone Generic | 11 | 11 | Under 11 | $59.14 |
Brand drugs: - claims; generic drugs: 265 claims; opioid claims: 75.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luis E Raez $33K ($33K in general payments such as food, travel and fees) from 21 companies. The largest payer was Janssen Scientific Affairs, LLC with $5,490.
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC JNJ | 4 | $5,490 |
| Janssen Biotech, Inc. JNJ | 6 | $5,298 |
| Abbvie Inc. ABBV | 4 | $4,350 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $2,914 |
| Immunitybio, Inc. IBRX | 1 | $2,500 |
| EMD Serono, Inc. MRK.DE | 1 | $2,375 |
| Nuvation Bio Inc. NUVB | 1 | $2,100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $2,030 |
| Amgen Inc. AMGN | 3 | $1,638 |
| Daiichi Sankyo Inc. 4568.T | 1 | $1,290 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.